Search clinical trials for: Sargrostim
Total 1 results
-
Mt. Sinai Medical Center, MiamiBayer; Chiron CorporationCompletedMalignant MelanomaUnited States
Sponsors and Collaborators
- Lilly PharmaceuticalCompany
- United States Department of Defense (DOD)
- University of Applied Sciences Jena
- S-Biotek Holding ApS
- Julian Taylor Green
- Plethora Solutions Ltd
- Oblikue Consulting
- Sudimplant SAS - Groupe TBR
- Paulo Sérgio Gomes Nogueira Borges
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Iyad Naeem Muhammad, PhD
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Gunkang Pharmaceuticals, Inc
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Rivierduinen, Centre for Personality disorders Jelgersma
- Eurotrials Brasil Consultores Cientificos Ltda
- Korea Otsuka International Asia Arab
- Arsha Vidya Tirtha
- Foshan Sanshui District People's Hospital
- View Full List
Medical Conditions
- Visual Attention Span Deficit
- Brain Tumor, Primary
- Serum Albumin Low
- Anemia Acute
- Hypothermia Following Anesthesia, Sequela
- Testicular Teratoma
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Advance Directive Completion
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Thyroid and Parathyroid Surgery
- Puberty, Delayed
- Blepharospasm of Both Eyelids
- Immunologically-induced Lung Disease
- Malaria,Falciparum
- Chemotherapy-Induced Neutropenia
- Huntington Chorea
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Deformity Flexion
- Vibration; Exposure
- Gray Platelet Syndrome
- View Full List
Drug Interventions
- Cytisine
- ABY-035 i.v.
- Cyanoacrylate
- Rovalpituzumab tesirine
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- MMV390048 120mg
- Vosaroxin
- Mineralocorticoid receptor antagonist
- S-Adenosyl-Methionine
- Oxycodone
- Standard medical therapy
- F520
- Pemetrexed
- Acalabrutinib in combination with VR
- Bimatoprost 0.03% eye drops
- Pegfilgrastim
- Furmonertinib 160 mg
- Sorafenib
- Ebselen
- Celecoxib
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Croatia
- Contract Research Organizations in Estonia
- Contract Research Organizations in Gambia
- Contract Research Organizations in Germany
- Contract Research Organizations in Greece
- Contract Research Organizations in Italy
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Portugal
- Contract Research Organizations in Suriname
- Contract Research Organizations in Uruguay
- CRO list by country